Last reviewed · How we verify
NCT00415766
Recombinant hCG (Ovitrelle) Vesrus Urinary hCG (Pregnyl) for Triggering Final Oocyte Maturation in High Responders
Phase 4 trial testing rHCG 250ug in Infertility in 150 participants. Status unknown.
1 December 2015
Quick facts
| Lead sponsor | Eugonia |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 June 2013 |
| Primary completion | 1 December 2015 |
| Estimated completion | 1 July 2016 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- rHCG 250ug — full drug profile →
- uHCG 5000 IU — full drug profile →
- uHCG 7500 IU — full drug profile →
Conditions studied
- Infertility — all drugs for Infertility →
Sponsor
Eugonia — full company profile →
Who can join
Adults 18 to 39, female only, with Infertility. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Percentage of mature oocytes
Time frame: Day of oocyte retrieval (Day 0)
Percentage MII/COCs
Sponsor's own description
The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT00415766
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Eugonia trials
Trials by the same sponsor.
- NCT06019494 — Comparison of 2 Different Flow Rates During Oocyte Retrieval · NA · completed
- NCT05473455 — Value of Follicular Flushing. Randomised Controlled Trial · NA · completed
- NCT03610009 — 2D Versus SonoAVC Scanning in High Responders · NA · unknown
- NCT03354858 — Follicular Flushing Versus Direct Aspiration · completed
- NCT03353285 — Effect of Follicle Flushing on Oocyte Fertilization Rate · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00415766 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eugonia
- Last refreshed: 18 January 2016
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00415766.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing